China NMPA Inspection - Jilin Ruierkang Contact Lens Co., Ltd. - November 02, 2016

An unannounced inspection conducted by the Jilin Provincial Food and Drug Administration (part of the NMPA regulatory framework) identified significant non-compliance issues at Jilin Ruierkang Contact Lens Co., Ltd. The inspection report, published on November 2, 2016, detailed critical deficiencies within the company's quality management system.The primary violations observed were in the company's adherence to the Good Manufacturing Practice for Medical Devices (GMP). These findings indicate that Jilin Ruierkang Contact Lens Co., Ltd. failed to meet the essential standards required for manufacturing medical devices, specifically contact lenses. Such non-compliance typically involves inadequate control over production processes, quality assurance, documentation, and personnel training, all of which are crucial for ensuring product safety and efficacy.Consequently, the Jilin Provincial Food and Drug Administration has issued a clear directive to Jilin Ruierkang Contact Lens Co., Ltd., mandating the rectification of all identified deficiencies. The company is required to implement corrective actions within a specified timeframe to bring its operations into full compliance with the regulatory requirements. This enforcement action underscores the regulator's commitment to upholding product quality and patient safety in the medical device sector.